Lopez stop taking rubbish they have a 10 mill facility with langstead which is more than enough for pre-p3 studies then phase 3 trial funding will be incorporated into a deal - it won’t be neu’s problem and you know this, it’s quite standard for this stage in development .
They have clearly stated the whole time a deal is on the table
Ann: Neuren FDA meeting confirms Phase 3 plan for Rett syndrome, page-95
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.02 |
Change
0.080(0.62%) |
Mkt cap ! $1.664B | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.35 | $12.99 | $5.557M | 423.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1588 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.06 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |